Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASSIST-RT: GP2013 Switch Study in Rheumatoid Arthritis
NCT02514772Phase 3Completed
- Sponsor
- Sandoz
- Start
- Jul 2015
- Primary completion
- Jul 2016
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 3 trial of rituximab in rheumatoid arthritis (RA), sponsored by Sandoz. Started Jul 2015; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02514772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02514772.